|
1
|
Mangion K, Gao H, Husmeier D, Luo X and
Berry C: Advances in computational modelling for personalised
medicine after myocardial infarction. Heart. 104:550–557.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Heusch G and Gersh BJ: The pathophysiology
of acute myocardial infarction and strategies of protection beyond
reperfusion: A continual challenge. Eur Heart J. 38:774–784.
2017.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Boersma E, Mercado N, Poldermans D,
Gardien M, Vos J and Simoons ML: Acute myocardial infarction.
Lancet. 361:847–858. 2003.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Reed GW, Rossi JE and Cannon CP: Acute
myocardial infarction. Lancet. 389:197–210. 2016.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Michaels AD, Gibson CM and Barron HV:
Microvascular dysfunction in acute myocardial infarction: Focus on
the roles of platelet and inflammatory mediators in the no-reflow
phenomenon. Am J Cardiol. 85:50B–60B. 2000.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Maier W, Altwegg LA, Corti R, Gay S,
Hersberger M, Maly FE, Sütsch G, Roffi M, Neidhart M, Eberli FR, et
al: Inflammatory markers at the site of ruptured plaque in acute
myocardial infarction: Locally increased interleukin-6 and serum
amyloid A but decreased C-reactive protein. Circulation.
111:1355–1361. 2005.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Pop M, Qi X, Barry J, Strauss BH, Wright
GA and Ghugre NR: Hemorrhage promotes inflammation and myocardial
damage following acute myocardial infarction. J Cardiovasc Magn
Reson. 16 (Suppl 1)(O72)2014.
|
|
8
|
Westman PC, Lipinski MJ, Luger D, Waksman
R, Bonow RO, Wu E and Epstein SE: Inflammation as a driver of
adverse left ventricular remodeling after acute myocardial
infarction. J Am Coll Cardiol. 67:2050–2060. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Ong SB, Hernández-Reséndiz S,
Crespo-Avilan GE, Mukhametshina RT, Kwek XY, Cabrera-Fuentes HA and
Hausenloy DJ: Inflammation following acute myocardial infarction:
Multiple players, dynamic roles, and novel therapeutic
opportunities. Pharmacol Ther. 186:73–87. 2018.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Eindhoven DC, Hilt AD, Zwaan TC, Schalij
MJ and Borleffs CJW: Age and gender differences in medical
adherence after myocardial infarction: Women do not receive optimal
treatment - The Netherlands claims database. Eur J Prev Cardiol.
25(2047487317744363)2017.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Sun HY, Lee JH, Han YS, Yoon YM, Yun CW,
Kim JH, Song YS and Lee SH: Pivotal roles of ginsenoside Rg3 in
tumor apoptosis through regulation of reactive oxygen species.
Anticancer Res. 36:4647–4654. 2016.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Tang YC, Yan Z, Jin Z, Zhi Q, Wu MY, Gong
FR, Shen M, Liu L, Tao M, Shen B, et al: Ginsenoside Rg3 targets
cancer stem cells and tumor angiogenesis to inhibit colorectal
cancer progression in vivo. Int J Oncol. 52:127–138.
2018.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lee B, Sur B, Park J, Kim SH, Kwon S, Yeom
M, Shim I, Lee H and Hahm DH: Ginsenoside Rg3 alleviates
lipopolysaccharide-induced learning and memory impairments by
anti-inflammatory activity in rats. Biomol Ther (Seoul).
21:381–390. 2013.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Zhang LP, Jiang YC, Yu XF, Xu HL, Li M,
Zhao XZ and Sui DY: Ginsenoside Rg3 improves cardiac function after
myocardial ischemia/reperfusion via attenuating apoptosis and
inflammation. Evid Based Complement Alternat Med.
2016(6967853)2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yang JL, Ha TK, Dhodary B, Kim KH, Park J,
Lee CH, Kim YC and Oh WK: Dammarane triterpenes as potential SIRT1
activators from the leaves of Panax ginseng. J Nat Prod.
77:1615–1623. 2014.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Wang Y, Chen Y, Wang H, Cheng Y and Zhao
X: Specific turn-on fluorescent probe with aggregation-induced
emission characteristics for SIRT1 modulator screening and
living-cell imaging. Anal Chem. 87:5046–5049. 2015.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Kauppinen A, Suuronen T, Ojala J, Kai K
and Salminen A: Antagonistic crosstalk between NF-κB and SIRT1 in
the regulation of inflammation and metabolic disorders. Cell
Signal. 25:1939–1948. 2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Jankowski M, Bissonauth V, Gao L, Gangal
M, Wang D, Danalache B, Wang Y, Stoyanova E, Cloutier G, Blaise G
and Gutkowska J: Anti-inflammatory effect of oxytocin in rat
myocardial infarction. Basic Res Cardiol. 105:205–218.
2010.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen GD, Yu WD and Chen XP: SirT1
activator represses the transcription of TNF-α in THP-1 cells of a
sepsis model via deacetylation of H4K16. Mol Med Rep. 14:5544–5550.
2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
National Research Council. Guide for the
care and use of laboratory animals. National Academies Press,
2010.
|
|
21
|
Sun Q, Kang Z, Cai J, Liu W, Liu Y, Zhang
JH, Denoble PJ, Tao H and Sun X: Hydrogen-rich saline protects
myocardium against ischemia/reperfusion injury in rats. Exp Biol
Med (Maywood). 234:1212–1219. 2009.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Tao J, Zhang J, Ling Y, McCall CE and Liu
TF: Mitochondrial sirtuin 4 resolves immune tolerance in monocytes
by rebalancing glycolysis and glucose oxidation homeostasis. Front
Immunol. 9(419)2018.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Mehta LS, Beckie TM, Devon HA, Grines CL,
Krumholz HM, Johnson MN, Lindley KJ, Vaccarino V, Wang TY, Watson
KE, et al: Acute myocardial infarction in women: A scientific
statement from the American Heart Association. Circulation.
133(916)2016.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Toggweiler S, Sabti Z and Cuculi F:
Prehospital ticagrelor in ST-segment elevation myocardial
infarction. South China J Cardiol. 9:657–659. 2016.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Ruparelia N, Godec J, Lee R, Chai JT,
Dall'Armellina E, McAndrew D, Digby JE, Forfar JC, Prendergast BD,
Kharbanda RK, et al: Acute myocardial infarction activates distinct
inflammation and proliferation pathways in circulating monocytes,
prior to recruitment, and identified through conserved
transcriptional responses in mice and humans. Eur Heart J.
36:1923–1934. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Prabhu SD and Frangogiannis NG: The
biological basis for cardiac repair after myocardial infarction:
From inflammation to fibrosis. Circ Res. 119:91–112.
2016.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Shin YM, Jung HJ, Choi WY and Lim CJ:
Antioxidative, anti-inflammatory, and matrix metalloproteinase
inhibitory activities of 20(S)-ginsenoside Rg3 in cultured
mammalian cell lines. Mol Biol Rep. 40:269–279. 2013.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Lee IS, Uh IJ, Kim KS, Kim KH, Park J, Kim
Y, Jung JH, Jung HJ and Jang HJ: Anti-inflammatory effects of
ginsenoside Rg3 via NF-κB pathway in A549 cells and human asthmatic
lung tissue. J Immunol Res. 2016(7521601)2016.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Brasier AR: The nuclear
factor-kappaB-interleukin-6 signalling pathway mediating vascular
inflammation. Cardiovasc Res. 86:211–218. 2010.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Khanna AK, Jianping X and Mehra MR:
Antioxidant N-acetyl cysteine reverses cigarette smoke-induced
myocardial infarction by inhibiting inflammation and oxidative
stress in a rat model. Lab Invest. 92:224–235. 2012.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Annacker O, Pimenta-Araujo R,
Burlen-Defranoux O, Barbosa TC, Cumano A and Bandeira A:
CD25+ CD4+ T cells regulate the expansion of
peripheral CD4 T cells through the production of IL-10. J Immunol.
166:3008–3018. 2001.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Dardalhon V, Awasthi A, Kwon H, Galileos
G, Gao W, Sobel RA, Mitsdoerffer M, Strom TB, Elyaman W, Ho IC, et
al: IL-4 inhibits TGF-beta-induced Foxp3+ T cells and,
together with TGF-beta, generates IL-9+
IL-10+ Foxp3(-) effector T cells. Nat Immunol.
131:1347–1355. 2008.PubMed/NCBI View
Article : Google Scholar
|
|
34
|
Timóteo RP, Silva AF, Micheli DC, Candido
Murta EF, Freire M, Teodoro RB, Lima FM, Martins Tavares Murta B
and Bertoncello D: Increased flexibility, pain reduction and
unaltered levels of IL-10 and CD11b + lymphocytes in patients with
systemic lupus erythematosus were associated with kinesiotherapy.
Lupus. 27:1159–1168. 2018.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Fujii S and Lotze MT: Interleukin-10
(IL-10). Cancer Drug Discov Dev: 165-179, 2007.
|
|
36
|
Dambuza IM, He C, Choi JK, Yu CR, Wang R,
Mattapallil MJ, Wingfield PT, Caspi RR and Egwuagu CE: IL-12p35
induces expansion of IL-10 and IL-35-expressing regulatory B cells
and ameliorates autoimmune disease. Nat Commun.
8(719)2017.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Groux H and Cottrez F: The complex role of
interleukin-10 in autoimmunity. J Autoimmun. 20:281–285.
2003.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Lai M, Du G, Shi R, Yao J, Yang G, Wei Y,
Zhang D, Xu Z, Zhang R, Li Y, et al: miR-34a inhibits migration and
invasion by regulating the SIRT1/p53 pathway in human SW480 cells.
Mol Med Rep. 11:3301–3307. 2015.PubMed/NCBI View Article : Google Scholar
|
|
39
|
LI X and Jiang W: GW26-e0454 renalase
protects the cardiomyocytes of Sprague-Dawley rats against ischemia
and reperfusion injury by reducing myocardial cell necrosis and
apoptosis. J Am Coll Cardiol. 66:C43. 2015.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kim EK and Choi EJ: Compromised MAPK
signaling in human diseases: An update. Arc Toxicol. 89:867–882.
2015.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Wagner SA, Satpathy S, Beli P and
Choudhary C: SPATA2 links CYLD to the TNF-α receptor signaling
complex and modulates the receptor signaling outcomes. EMBO J.
35:1868–1884. 2016.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Baker R, Hayden M and Ghosh S: NF-κB,
inflammation, and metabolic disease. Cell Metab. 13:11–22.
2011.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Ghosh S and Hayden MS: New regulators of
NF-kappaB in inflammation. Nat Rev Immunol. 8:837–848.
2008.PubMed/NCBI View
Article : Google Scholar
|
